Course curriculum

    1. Welcome!

    2. Mark Haden

    3. Dr. Devon Christie

    4. Bruce Sanguin

    5. Saundra Jain

    6. Dr. Rakesh Jain

    7. Dr. Anthony Bossis

    8. Dr. Ben Malcolm

    9. Kim Haxton

    10. Alex Belser

    11. Susan McBride/Mark Cornfield

    12. Rich Tyo

    13. Mike Mathers

    14. Paul Bridger

    15. Zach Walsh

    16. Jane Cooper

    17. Trevor Miller

    18. Matthew Keleman

    19. Jeff Sorensen

    20. Thomas Hartle

    21. Pam Kryskow

    22. Rachel Dundas

    23. Ravinder Bains

    24. Scott Shannon

    25. Aviva Zohar

    26. Robert Strayhan, MD Psychiatry

    27. Assignments Overview, Instructions and 1st meeting agenda

    28. Assignment #1 - Psychedelic Innovator Review

    29. Assignment #2 - The Ethical Psychedelic Facilitator

    30. Assignment #3 - Non-Psychedelic Altered State of Consciousness Experience

    1. M1 Overview: Psychedelics are Medicine - Mark Haden

    2. M1 Overview: The Categories of Psychedelics - Mark Haden

    3. Copy of M1 Overview: Psychedelics - Nature vs Lab - Dr. Rakesh Jain

    4. M1 Overview: The Benefits of the Psychedelic Experience - Alex Belser

    5. M1 History: History Of Psychedelics - Mark Haden

    6. M1 History: Untold History Of Psychedelics - Mark Haden

    7. M1 Current Study and Research of Psychedelics: Section 56 Exemptions, SAP and Trials-Accessing Psychedelics - Mark Haden

    8. M1 Current Study and Research of Psychedelics: Microdosing Psychedelics - Zach Walsh

    9. M1 BONUS MATERIAL: Current Study and Research of Psychedelics: Microdosing Survey Outcomes - Zach Walsh

    10. M1 Current Study and Research of Psychedelics: Psychedelics and Wellness Study 2019 - Saundra Jain

    11. M1 Additional Resources on Current Research in Psychedelic Use

    12. Module 1 Review

    1. M2 The Psychedelic Medicines-Types and Descriptions: The "Signatures" of the Commonly Utilized Psychedelic Medicines - Bruce Sanguin

    2. M2 The Psychedelic Medicines-Types and Descriptions: Psilocybin - Mark Haden

    3. M2 The Psychedelic Medicines-Types and Descriptions: MDMA - Mark Haden

    4. M2 The Psychedelic Medicines-Types and Descriptions: MDMA and Psilocybin-Clinical Indications - Alex Belser

    5. M2 The Psychedelic Medicines-Types and Descriptions: DMT and 5-MeO-DMT - Mark Haden

    6. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 2C-B - Mark Haden

    7. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 3-MMC - Mark Haden

    8. M2 The Psychedelic Medicines-Types and Descriptions: LSD - Mark Haden

    9. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions : MEAI - Mark Haden

    10. M2 The Psychedelic Medicines-Types and Descriptions: Iboga: Effective Uses And Protocols - Trevor Millar

    11. M2 The Psychedelic Medicines-Types and Descriptions: Ketamine - Dr. Mark Cornfield And Susan McBride

    12. M2 The Psychedelic Medicines-Types and Descriptions: Patented Ketamine Products - Dr. Mark Cornfield And Susan McBride

    13. M2 The Psychedelic Medicines-Types and Descriptions: Why Choose Ketamine Over Other Psychedelics For Your Clients? - Dr. Mark Cornfield And Susan McBride

    14. M2 The Psychedelic Medicines-Types and Descriptions: Ketamine Protocols - Dr. Mark Cornfield And Susan McBride

    15. M2 The Psychedelic Medicines-Types and Descriptions: The Ketamine First Aid Kit - Dr. Mark Cornfield And Susan McBride

    16. M2 The Psychedelic Medicines-Types and Descriptions: Maximizing The Benefits in Ketamine Application - Dr. Rakesh Jain

    17. M2 The Psychedelic Medicines-Types and Descriptions: Psychedelics And The Four Neurotransmitters - Dr Rakesh Jain

    18. M2 The Psychedelic Medicines-Types and Descriptions: Comparing Effects and Outcomes of Psilocybin, MDMA and Ketamine Therapy - Zach Walsh

    19. M2 The Psychedelic Medicines-Types and Descriptions: The Indigenous Medicines Of Turtle Island - Kim Haxton

    20. M2 The Psychedelic Medicines-Types and Descriptions: Yopo: Indigenous Path to Psychedelic Medicine Use - Paul Bridger

    21. M2 The Psychedelic Medicines-Types and Descriptions: Traditional Plant Medicine Ceremonies vs Western Psychedelic Therapy - Kim Haxton

    22. M2 The Psychedelic Medicines-Neurobiology: Pharmacology in Relation to Psychedelics - Ben Malcolm

    23. M2 The Psychedelic Medicines-Neurobiology: Neurobiology and Effects of Psychedelics - Ben Malcolm

    24. M2 The Psychedelic Medicines-Neurobiology: Leading Theories in Neurobiology for Psychedelics - Ben Malcolm

    25. M2 The Psychedelic Medicines-Neurobiology: Overview of MDMA - Ben Malcolm

    26. M2 The Psychedelic Medicines-Neurobiology: MDMA Side Effects - Ben Malcolm

    27. M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacodynamics - Ben Malcolm

    28. M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacokinetics - Ben Malcolm

    29. M2 The Psychedelic Medicines-Neurobiology : MDMA Drug Interactions - Ben Malcolm

    30. M2 The Psychedelic Medicines-Neurobiology: Seratonin Syndrome/Toxicity - Ben Malcolm

    31. M2 The Psychedelic Medicines-Neurobiology: Overview of Psilocybin - Ben Malcolm

    32. M2 The Psychedelic Medicines-Neurobiology: Psilocybin Pharmacodynamics and Pharmacokinetics - Ben Malcolm

    33. M2 The Psychedelic Medicines-Neurobiology: Psilocybin Drug Interactions - Ben Malcolm

    34. M2 The Psychedelic Medicines-Neurobiology: Ketamine Overview - Ben Malcolm

    35. M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacodynamics - Ben Malcolm

    36. M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacokinetics - Ben Malcolm

    37. M2 The Psychedelic Medicines-Neurobiology : Ketamine Drug Interactions - Ben Malcolm

    38. M2 The Psychedelic Medicines-Neurobiology: Final Thoughts-The Data Will Set Us Free - Ben Malcolm

    39. Module 2 Review

    1. M3 Access and Inclusivity: Indigenous Perspectives - The Challenges of Bringing Psychedelics and Psychedelic-Assisted Therapy to Diverse Communities - Kim Haxton

    2. M3 Access and Inclusivity: Indigenous Perspectives - The Stigma of Psychedelics Among Indigenous Communities - Kim Haxton

    3. M3 Access and Inclusivity: Indigenous Perspectives - Becoming an Effective Facilitator for Diverse Communities - Kim Haxton

    4. M3 Access and Inclusivity: Indigenous Perspectives - Strategies for Collaboration between Western and Indigenous Approaches to PaT - Kim Haxton

    5. M3 Access and Inclusivity: Indigenous Perspectives - Our Relationship with the Natural World as the Other - Kim Haxton

    6. M3 Access for Diverse and Under-privileged Populations: - Making PaT Accessible for Everyone - It takes the Community - Paul Bridger

    7. M3 Access for Diverse and Under-privileged Populations: The Future of Accessibility - Alex Belser

    8. M3 Cultural Considerations: What We Need To Know About Psychedelics, LGBTQIA+ and BIPOC - Alex Belser

    9. Module 3 Review

    1. M4 Psychedelic Altered States of Consciousness: The Transformational Power Of Psychedelics - Bruce Sanguin

    2. M4 Psychedelic Altered States of Consciousness : Finding Spiritual Tools Through Psychedelics - Trevor Millar

    3. M4 Psychedelic Altered States of Consciousness: Transformative Experiences - Trevor Millar

    4. M4 Non-Psychedelic Altered States of Consciousness : Altered States Of Consciousness Without Psychedelic Medicine - Kim Haxton

    5. M4 Non-Psychedelic Altered States of Consciousness: Altered States Without Psychedelics - Matthew Kelemen

    6. M4 Non-Psychedelic Altered States of Consciousness: Breathwork-Cold Therapy - Jeff Sorensen

    7. M4 Non-Psychedelic Altered States of Consciousness: Meditation - Matthew Kelemen

    8. M4 Non-Psychedelic Altered States of Consciousness: Yoga - Matthew Kelemen

    9. M4 Non-Psychedelic Altered States of Consciousness: Yoga and Meditation with Psychedelics - Matthew Kelemen

    10. M4 Non-Psychedelic Altered States of Consciousness: Medicinal Cannabis - Rich Tyo

    11. M4 The Mystical Side of Psychedelics: The MEQ - Is this an Accurate Measure of the Full Experience? - Alex Belser

    12. M4 The Mystical Side of Psychedelics: Psychedelic Research and the Mystical Experience - Anthony Bossis

    13. M4 The Mystical Side of Psychedelics: Psychedelics and Religion - Bruce Sanguin

    14. Module 4 Review

    1. M5 Therapist Personal Development: The Importance Of Personal Psychedelic Work - Bruce Sanguin

    2. M5 Therapist Personal Development: Becoming A Love Warrior - Mike Mathers

    3. M5 Therapist Personal Development: Love Warrior Principles for the Psychedelic Therapist - Mike Mathers

    4. M5 Therapist Personal Development: What Is Your Lived Experience - Kim Haxton

    5. M5 Basic Principles of Guiding/Sitting: - The Value Of Working Within A Team Of Psychedelic Therapists - Pam Kryskow

    6. M5 Basic Principles of Guiding/Sitting: Fearlessness - An Essential Trait of Effective Psychedelic Therapy - Bruce Sanguin

    7. M5 Basic Principles of Guiding/Sitting: The Role of the Psychedelic Guide - Tracking the Client in their Journey - Bruce Sanguin

    8. M5 Dosage Considerations: Three Principles for an Effective Psychedelic Experience - Trevor Millar

    9. M5 Basic Principles of Guiding/Sitting: The Role of the Guide Sitter for Ketamine-Assisted Therapy - Mark Cornfield And Susan McBride

    10. M5 Basic Principles of Guiding/Sitting: A Pragmatic Approach to Trauma-Informed Psychedelic Work - Rakesh Jain

    11. M5 Basic Principles of Guiding/Sitting: The Different Levels of Interaction in PaT - Rich Tyo

    12. M5 Basic Principles of Guiding/Sitting: The Different Levels of Interaction in PaT - Rich Tyo

    13. M5 Basic Principles of Guiding/Sitting: Indigenous Practices for PaT - Paul Bridger

    14. M5 Basic Principles of Guiding/Sitting: What makes an Effective Psychedelic-Assisted Psychotherapist - Mike Mathers

    15. M5 Self-Care for the Facilitator: Therapist Support Networks for Self-Care - Saundra Jain

    16. M5 Self-Care for the Facilitator: Self-Care and Preparation for the Therapist - Anthony Bossis

    17. M5 Self-Care for the Facilitator: Personal Outcomes for the Therapist - Anthony Bossis

    18. M5 Self-Care for the Facilitator: Pre and Post PaT Self-Care for the Therapist - Paul Bridger

    19. Module 5 Review

About this course

  • $5,600.00
  • 238 lessons
  • 1.5 hours of video content